PointsBet Holdings Earnings Call Transcripts
Fiscal Year 2025
-
FY25 saw record revenue and first full-year gross profitability, with normalized EBITDA of $11.2 million and strong growth in both Australia and Canada. The board recommends Mixi Australia's $1.25/share cash offer, while Betar's scrip bid is rejected due to lack of control and synergy risks.
-
Shareholders considered a scheme for MIXI to acquire all shares at AUD 1.20, with strong board and independent expert support. Despite a blocking stake by Betr, the majority of proxies favored the scheme, which offers a significant premium and certainty amid competitive and regulatory challenges.
-
Entered a Scheme with MIXI at a 27.7% premium; H1 FY25 revenue up 6% and EBITDA loss improved by AUD 10 million year-over-year. Australia and Canada segments showed strong growth in actives and gross profit, with positive cash flow expected in H2.
-
Achieved first full-year EBITDA profitability, driven by revenue growth and improved gross profit efficiency, despite customer-friendly outcomes and VIP softness. FY25 EBITDA guidance narrowed, revenue guidance lowered, but gross profit margins and long-term targets remain on track.
-
Q1 FY 2025 delivered 12% net win growth and 15% gross profit growth, led by strong sports betting and iGaming performance in Australia and Canada. Guidance for FY 2025 is reaffirmed, with continued investment in innovation and market share gains.
Fiscal Year 2024
-
The meeting highlighted record financial results, the successful sale of the U.S. business, and significant capital returns to shareholders. Strategic focus remains on growth in Australia and Canada, responsible gambling, and readiness for industry consolidation. Voting on resolutions proceeded smoothly, with one withdrawn due to market cap.
-
Completed U.S. business sale and returned AUD 442.4 million to shareholders. FY 2024 saw strong revenue and margin growth, with Australia and Canada outperforming and significant improvements in EBITDA. FY 2025 guidance targets 14–18% revenue growth, positive EBITDA, and cash flow breakeven.
-
Completed U.S. business sale and returned $442.4M to shareholders. FY24 net win rose 16% year-over-year, with normalized EBITDA loss improving to $1.8M. Both Australian and Canadian segments delivered strong growth, and the company remains well-capitalized.